Roy Lardenoije

Roy Lardenoije

Auto-generated profile, based on publicly available information

Roy Lardenoije

Department of Intelligent Systems, Delft University of Technology, Delft, Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2025 in bioRxiv
Verified
Preprint
Open access
AKAngela R.S. Kruse
Angela R.S. Kruse
RLRoy Lardenoije
Roy Lardenoije
LMLukasz G. Migas
Lukasz G. Migas
CSClaire F. Scott
Claire F. Scott
CMCody Marshall
Cody Marshall
JSJeffrey M. Spraggins
Jeffrey M. Spraggins
Summary: Spatial ’omics technologies are a powerful tool for mapping the relationship between cellular organization and molecular distributions in healthy and diseased tissue microenvironments. Here, we describe a novel multimodal pipeline that represents experimental and computational advances for spatiomolecular analysis of tissue samples across molecular classes. This adaptable method integrates matrix-assisted laser desorption/ionization imaging mass spectrometry spatial lipidomics, spatial transcriptomics, protein imaging via multiplexed immunofluorescence microscopy, and histopathological staining to uncover spatiomolecular profiles associated with unique cellular niches and pathological features. We demonstrate the power of this approach using two different complex human disease systems: Alzheimer’s disease in human brain tissue and type 2 diabetes mellitus in the human pancreas. This work establishes and demonstrates a generalizable framework for multimodal spatial integration, enabling precise mapping of molecular mechanisms that underlie complex tissue pathologies.

26 September 2025
Verified
Preprint
Open access
PDF file
ASAnna Smith
Anna Smith
KDKaterina Djambazova
Katerina Djambazova
JAJamie Allen
Jamie Allen
RLRoy Lardenoije
Roy Lardenoije
MFMelissa Farrow
Melissa Farrow
JSJeff Spraggins
Jeff Spraggins
This is a protocol for preparing fresh-frozen kidney tissue for in situ spatial transcriptomics using a custom probe panel with the 10X Xenium Analyzer platform. Slide preparation is a multi-day process encompassing cryosectioning, probe hybridization, subsequent ligation and amplification, quenching and nuclei staining, and in situ imaging. Each phase of the workflow is extensively detailed within published 10X User Guides, which are cited throughout this version. After data is collected, slides are H&E stained for histopathological evaluation of healthy and diseased tissue, and used for integrated data registration to neighboring images and modalities. There are sample evaluation and QC measures built into the 10X protocols, which are carefully observed in addition to our own go/no-go criteria.

28 April 2022 in Biological Psychiatry
Verified
Journal Article
Closed access
PDF file
JOJoy Otten
Joy Otten
SDShu Dan
Shu Dan
RLRoy Lardenoije
Roy Lardenoije
TKTorsten Klengel
Torsten Klengel

29 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RRRjm Riemens
Rjm Riemens
EPE Pishva
E Pishva
AIA Iatrou
A Iatrou
JRJ Roubroeks
J Roubroeks
JNJ Nolz
J Nolz
DHDaniel van den Hove
Daniel van den Hove
Recent studies have demonstrated that the dorsal raphe nucleus (DRN) is among the first brain regions affected in Alzheimer’s disease. Hence, in this study we conducted the first comprehensive epigenetic analysis of the DRN in AD, targeting both bulk tissue and single isolated cells. The Illumina Infinium MethylationEPIC BeadChip array was used to analyze the bulk tissue, assessing differentially modified positions (DMoPs) and regions (DMoRs) associated with Braak stage. The strongest Braak stage-associated DMoR in TNXB was targeted in a second patient cohort utilizing single laser-capture microdissected serotonin-positive (5-HT+) and -negative (5-HT-) cells isolated from the DRN. Our study revealed previously identified epigenetic loci, including TNXB and PGLYRP1 , and novel loci, including RBMXL2 , CAST , GNAT1 , MALAT1 , and DNAJB13 . Strikingly, we found that the methylation profile of TNXB depends both on disease phenotype and cell type analyzed, emphasizing the significance of single cell(-type) neuroepigenetic studies in AD.